[go: up one dir, main page]

HN2001000039A - Soluciones de acido acetisalicilico - Google Patents

Soluciones de acido acetisalicilico

Info

Publication number
HN2001000039A
HN2001000039A HN2001000039A HN2001000039A HN2001000039A HN 2001000039 A HN2001000039 A HN 2001000039A HN 2001000039 A HN2001000039 A HN 2001000039A HN 2001000039 A HN2001000039 A HN 2001000039A HN 2001000039 A HN2001000039 A HN 2001000039A
Authority
HN
Honduras
Prior art keywords
acetisalicilic
acid solutions
solutions
acid
aas
Prior art date
Application number
HN2001000039A
Other languages
English (en)
Inventor
Wolfgang Wiehl
Martina Wirtz
Dietmar Bahn
Original Assignee
Bayer Aftiengesellschft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aftiengesellschft filed Critical Bayer Aftiengesellschft
Publication of HN2001000039A publication Critical patent/HN2001000039A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A SOLUCIONES DE ACIDO ACETILSALICILICO (AAS) Y A AGENTES BASADOS EN ESTAS SOLUCIONES PARA EL TRATAMIENTOTOPICO DEL DOLOR.
HN2001000039A 2000-03-07 2001-03-05 Soluciones de acido acetisalicilico HN2001000039A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10011032A DE10011032A1 (de) 2000-03-07 2000-03-07 Acetylsalicylsäure-Lösungen

Publications (1)

Publication Number Publication Date
HN2001000039A true HN2001000039A (es) 2001-07-09

Family

ID=7633806

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2001000039A HN2001000039A (es) 2000-03-07 2001-03-05 Soluciones de acido acetisalicilico

Country Status (9)

Country Link
EP (1) EP1263441A2 (es)
AR (1) AR028237A1 (es)
AU (1) AU2001272099A1 (es)
DE (1) DE10011032A1 (es)
GT (1) GT200100035A (es)
HN (1) HN2001000039A (es)
PE (1) PE20030207A1 (es)
SV (1) SV2002000339A (es)
WO (1) WO2001066115A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070196460A1 (en) * 2004-02-16 2007-08-23 Yukiko Inamoto External preparation for treating skin or mucosal injury caused by viral infection
WO2007125492A2 (en) * 2006-05-02 2007-11-08 Pfeinsmith S.A. (Pty) Ltd Acidic composition
JP7335232B2 (ja) * 2017-05-30 2023-08-29 ローシャン ファーマシューティカルズ，インコーポレーテッド 安定な滅菌性且つ結晶性ｏ－アセチルサリチル酸（アスピリン）のバイアル内堆積物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
WO1995019759A1 (en) * 1994-01-24 1995-07-27 The Procter & Gamble Company Process for solubilizing difficultly soluble pharmaceutical actives
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives

Also Published As

Publication number Publication date
EP1263441A2 (de) 2002-12-11
AR028237A1 (es) 2003-04-30
AU2001272099A1 (en) 2001-09-17
GT200100035A (es) 2001-12-18
WO2001066115A3 (de) 2002-02-14
WO2001066115A2 (de) 2001-09-13
SV2002000339A (es) 2002-06-07
DE10011032A1 (de) 2001-09-13
PE20030207A1 (es) 2003-04-16

Similar Documents

Publication Publication Date Title
HN2001000190A (es) Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento
HN1999000015A (es) Tratamiento para una disfuncion sexual femenina
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
HN1999000096A (es) Formulaciones intranasales para tratar trastornos sexuales
HN1999000045A (es) Derivados biciclicos del acido hidroxamico
AR026163A1 (es) Utilizacion de retigabina para el tratamiento de dolores neuropaticos
AR024944A1 (es) Amidas de acidos carboxilicos, medicamentos que contienen estos compuestos, su utilizacion y su preparacion
HN1997000110A (es) Derivados del acido arilsulfoonilamino hidroxamico
GB0019283D0 (en) Organic compounds
HN2002000110A (es) Uso de (z) - 2 - ciano - 3 - hidroxi - butil - 2 - acido enoico (4' - trifluorometil fenilo) - amida para el tratamiento de la esclerosis multiple.
FI20000635A0 (fi) COMT-inhibiittoreiden käyttö analgeettina
DK1305037T3 (da) Smertestillende medikament
AR028772A1 (es) 5-aminoalquil-pirazol[4,3-d] pirimidinas
SE0004101D0 (sv) New use
HN2001000039A (es) Soluciones de acido acetisalicilico
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
BR0010699A (pt) Benzimidazóis substituìdos, sua produção e utilização dos mesmos como agente contra protozoários parasitários
ES2169399T3 (es) Procedimiento para preparar heterociclos de fenilo utiles como inhibidores de la cox-2.
HN2000000078A (es) Amidas sustituidas del acido fenilciclohexanocarboxilico y su uso como inhibidores de la incorporacion de adenosina
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
UY26608A1 (es) Soluciones de ácido acetilsalicílico
GT200000114A (es) Forma cristalina iii de la n-(4-(5-dimetilaminoftalen-1-sulfonilamino) fenil)-3-hidroxi-2, 2-dimetilpropionamida.
HN2001000214A (es) Alcanosulfonatos de fenoxifenilo
SE0300535D0 (sv) Treatment of burns